Dr.Jothydev spoke on "Newer Concepts in Management of Diabetes".Venue Hotel Vijeatha Dr.Vincent, President of API forum, chaired the session.Dr.Raja Paul introduced the speaker.Dr.Manohar C was aslo present.

One question and Answer:

Dr.Raja Paul:

The new GLP-1 analogues are introduced in the West and will be available in India also soon Do you think it will be safe or we need to wait for 4 to 5 years to say for sure thay are safe?

Dr.Jothydev:

It is left to individual Physicians.Rosiglitazone controversy has taught us many lessons on use of newer drugs. Exenatide belongs to a new class of drugs called Incretins with promises of weight loss and avoidance of hypos. The undesirable adverse effect of nausea and vomiting are the main limiting factors.We have to wait and see how beneficial these drugs are going to be compared to the already available safe and time tested anti hyperglycemic drugs.